SWOG clinical trial number
SWOG-8824

A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Advanced Renal Cell Carcinoma

Closed
Phase
Accrual
100%
Published
Abbreviated Title
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Advanced Renal Cell Carcinoma
Activated
05/01/1989
Closed
08/15/1991

Publication Information Expand/Collapse

1995

A phase II trial of continuous-infusion recombinant interleukin-2 in patients with advanced renal cell carcinoma: A Southwest Oncology Group study.

RP Whitehead;MK Wolf;DL Solanki;GP Hemstreet III;P Benedetto;SP Richman;RC Flanigan;ED Crawford Journal of Immunotherapy 18(2):104-114

1993

A phase II trial of continuous infusion recombinant interleukin-2 (rIL-2) in patients with advanced renal cell carcinoma. A Southwest Oncology Group study.

RP Whitehead;MK Wolf;DL Solanki;P Benedetto;RC Flanigan;ED Crawford ASCO 12:253(#799)